<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7135139/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Main results of studies on the activity of chloroquine or hydroxychloroquine on coronaviruses 
   <a rid="tb1fn1" ref-type="table-fn">a</a>
  </p>
 </caption>
 <thead>
  <tr>
   <th valign="top" colspan="1" rowspan="1" id="0-0-.">Reference</th>
   <th valign="top" colspan="1" rowspan="1" id="0-1-.">Compound(s)</th>
   <th valign="top" colspan="1" rowspan="1" id="0-2-.">Targeted virus</th>
   <th valign="top" colspan="1" rowspan="1" id="0-3-.">System used for antiviral activity screening</th>
   <th valign="top" colspan="1" rowspan="1" id="0-4-.">Antiviral effect</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td valign="top">
    <a rid="bib0012" ref-type="bibr">[12]</a>
   </td>
   <td valign="top">Chloroquine</td>
   <td valign="top">SARS-CoV</td>
   <td valign="top">Vero (African green monkey kidney) E6 cells</td>
   <td valign="top">EC 
    <sub>50</sub> = 8.8 ± 1.2 μM 
   </td>
  </tr>
  <tr>
   <td valign="top">
    <a rid="bib0016" ref-type="bibr">[16]</a>
   </td>
   <td valign="top">Chloroquine</td>
   <td valign="top"/>
   <td valign="top">Vero E6 cells</td>
   <td valign="top">EC 
    <sub>50</sub> = 4.4 ± 1.0 μM 
   </td>
  </tr>
  <tr>
   <td valign="top">
    <a rid="bib0017" ref-type="bibr">[17]</a>
   </td>
   <td valign="top">Chloroquine, chloroquine monophosphate, chloroquine diphosphate</td>
   <td valign="top">SARS-CoV (four strains)</td>
   <td valign="top">Vero 76 cells</td>
   <td valign="top">Chloroquine: EC 
    <sub>50</sub> = 1–4 μM 
    <br/>Chloroquine monophosphate: EC 
    <sub>50</sub> = 4–6 μM 
    <br/>Chloroquine diphosphate: EC 
    <sub>50</sub> = 3–4 μM 
   </td>
  </tr>
  <tr>
   <td valign="top"/>
   <td valign="top"/>
   <td valign="top"/>
   <td valign="top">BALB/c mice</td>
   <td valign="top">Intraperitoneal or intranasal chloroquine administration, beginning 4 h prior to virus exposure: 50 mg/kg but not 10 mg/kg or 1 mg/kg reduced for the intranasal route (but not the intraperitoneal route) viral lung titres from mean ± S.D. of 5.4 ± 0.5 to 4.4 ± 1.2 in log 
    <sub>10</sub> CCID 
    <sub>50</sub>/g at Day 3 (considered as not significant) 
   </td>
  </tr>
  <tr>
   <td valign="top">
    <a rid="bib0018" ref-type="bibr">[18]</a>
   </td>
   <td valign="top">Chloroquine, hydroxychloroquine</td>
   <td valign="top">SARS-CoV</td>
   <td valign="top">Vero cells</td>
   <td valign="top">Chloroquine: EC 
    <sub>50</sub> = 6.5 ± 3.2 μM 
    <br/>Hydroxychloroquine: EC 
    <sub>50</sub> = 34 ± 5 μM 
   </td>
  </tr>
  <tr>
   <td valign="top"/>
   <td valign="top"/>
   <td valign="top">Feline coronavirus</td>
   <td valign="top">Crandell–Reese feline kidney (CRFK) cells</td>
   <td valign="top">Chloroquine: EC 
    <sub>50</sub> &gt; 0.8 μM 
    <br/>Hydroxychloroquine: EC 
    <sub>50</sub> = 28 ± 27 μM 
   </td>
  </tr>
  <tr>
   <td valign="top">
    <a rid="bib0019" ref-type="bibr">[19]</a>
   </td>
   <td valign="top">Chloroquine</td>
   <td valign="top">HCoV-229E</td>
   <td valign="top">Human epithelial lung cells (L132)</td>
   <td valign="top">Chloroquine at concentrations of 10 μM and 25 μM inhibited HCoV-229E release into the culture supernatant</td>
  </tr>
  <tr>
   <td valign="top">
    <a rid="bib0020" ref-type="bibr">[20]</a>
   </td>
   <td valign="top">Chloroquine</td>
   <td valign="top">HCoV-OC43</td>
   <td valign="top">HRT-18 cells</td>
   <td valign="top">EC 
    <sub>50</sub> = 0.306 ± 0.0091 μM 
   </td>
  </tr>
  <tr>
   <td valign="top"/>
   <td valign="top"/>
   <td valign="top"/>
   <td valign="top">Newborn C57BL/6 mice; chloroquine administration transplacentally and via maternal milk</td>
   <td valign="top">100%, 93%, 33% and 0% survival rate of pups when mother mice were treated per day with 15, 5, 1 and 0 mg/kg body weight, respectively</td>
  </tr>
  <tr>
   <td valign="top">
    <a rid="bib0021" ref-type="bibr">[21]</a>
   </td>
   <td valign="top">Chloroquine</td>
   <td valign="top">Feline infectious peritonitis virus (FIPV)</td>
   <td valign="top">
    <i>Felis catus</i> whole fetus-4 cells 
   </td>
   <td valign="top">FIPV replication was inhibited in a chloroquine concentration-dependent manner</td>
  </tr>
  <tr>
   <td valign="top">
    <a rid="bib0022" ref-type="bibr">[22]</a>
   </td>
   <td valign="top">Chloroquine</td>
   <td valign="top">SARS-CoV</td>
   <td valign="top">Vero E6 cells</td>
   <td valign="top">EC 
    <sub>50</sub> = 4.1 ± 1.0 μM 
   </td>
  </tr>
  <tr>
   <td valign="top"/>
   <td valign="top"/>
   <td valign="top">MERS-CoV</td>
   <td valign="top">Huh7 cells (human liver cell line)</td>
   <td valign="top">EC 
    <sub>50</sub> = 3.0 ± 1.1 μM 
   </td>
  </tr>
  <tr>
   <td valign="top"/>
   <td valign="top"/>
   <td valign="top">HCoV-229E-GFP (GFP-expressing recombinant HCoV-229E)</td>
   <td valign="top">Huh7 cells (human liver cell line)</td>
   <td valign="top">EC 
    <sub>50</sub> = 3.3 ± 1.2 μM 
   </td>
  </tr>
  <tr>
   <td valign="top">
    <a rid="bib0003" ref-type="bibr">[3]</a>
   </td>
   <td valign="top">Chloroquine</td>
   <td valign="top">SARS-CoV-2</td>
   <td valign="top">Vero E6 cells</td>
   <td valign="top">EC 
    <sub>50</sub> = 1.13 μM 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>CCID 
    <sub>50</sub>, 50% cell culture infectious dose; CoV, coronavirus; EC 
    <sub>50</sub>, 50% effective concentration (mean ± S.D.); GFP, green fluorescent protein; HCoV, human coronavirus; MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome; S.D., standard deviation. 
   </p>
  </p>
  <p class="fn" charset="fn" id="tb1fn1">
   <p class="label">a</p>
   <p id="notep0002">See also 
    <a rid="bib0001" ref-type="bibr">[1]</a> ( 
    <a rid="tbl0001" ref-type="table">Table 1</a>) for additional references. 
   </p>
  </p>
 </tfoot>
</table>
